Cargando…
Olanzapine induced neuroleptic malignant syndrome
An 18 year old male diagnosed as a case of bipolar affective disorder (BPAD), developed neuroleptic malignant syndrome (NMS) following treatment with olanzapine (20 mg per day), an atypical antipsychotic drug. NMS is usually seen with typical antipsychotic drugs. The patient was diagnosed as a case...
Autores principales: | Patra, Bichitra Nanda, Khandelwal, Sudhir K., Sood, Mamta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608309/ https://www.ncbi.nlm.nih.gov/pubmed/23543750 http://dx.doi.org/10.4103/0253-7613.106448 |
Ejemplares similares
-
Olanzapine-Induced Neuroleptic Malignant Syndrome
por: Hosseini, Seyedhamze, et al.
Publicado: (2017) -
Olanzapine-induced Neuroleptic Malignant Syndrome
por: Saha, Pradeep Kumar, et al.
Publicado: (2017) -
Pituitary Macroadenoma Presenting with Multiple Psychiatric Complications
por: Sood, Mamta, et al.
Publicado: (2015) -
A case of neuroleptic malignant syndrome induced by olanzapine in postpartum period
por: Üstündağ, Mehmet, et al.
Publicado: (2007) -
Neuroleptic malignant syndrome in a patient with stable dose of olanzapine
por: Sahoo, Manoj Kumar, et al.
Publicado: (2017)